These results systematically revealed that PKG II inhibited EGF-induced migration of gastric cancer cells through blocking EGF/EGFR initiated signal transduction of PLCγ1 and MAP/ERK-mediated pathways. This evidence concerns the gene EGFR and gastric cancer.